Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.
G
-70,00%
5-year Growth Rate
R
3/5
5-year Risk Analysis
O
N/A
Outlook 12/26
W
-22977%
Margin of safety
T
-93,00%
Analyst Price Target
H
DOWN
50-week EMA Trend
Company Info
EPS Growth 5Y
66,26%
Revenue growth 5Y
-70,00%
Price growth 5Y
-97,22%
Market Cap
$0,02 B
Long-Term Debt
$0,03 B
Short Interest
0,15%
Quarterly earnings
09/25/2026
Dividend
$20,12
Dividend Yield
70,45%
Industry
Country
ISIN Number
VYNE Therapeutics Price Chart (USD)
1M
3M
YTD
1Y
2Y
5Y
10Y
20Y
Top growth stocks in the health care sector
| Stock | Rate of Return 5Y | Price 5Y | Div. 5Y | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|---|---|
|
VYNE Therapeutics
NasdaqCM:VYNE
|
-95,26% | -97,22% | 1,96% | -70,00% | 3/5 | -100,00% | -22977,11% | -93,00% | DOWN |
